Activin/Nodal signalling maintains pluripotency by controlling Nanog expression. - Wikidata - awgldk - TriplyDB

Activin/Nodal signalling maintains pluripotency by controlling Nanog expression.

Activin/Nodal signalling maintains pluripotency by controlling Nanog expression.

http://www.wikidata.org/entity/Q43121593

about

Activin/Nodal signaling controls divergent transcriptional networks in human embryonic stem cells and in endoderm progenitors HEB and E2A function as SMAD/FOXH1 cofactors Pluripotency factors regulate definitive endoderm specification through eomesodermin Nodal morphogens What Kind of Signaling Maintains Pluripotency and Viability in Human-Induced Pluripotent Stem Cells Cultured on Laminin-511 with Serum-Free Medium?Developmental signaling pathways regulating mammary stem cells and contributing to the etiology of triple-negative breast cancer Pluripotent Stem Cells: Current Understanding and Future Directions Pluripotency Factors on Their Lineage Move Common stemness regulators of embryonic and cancer stem cells Ex uno plures: molecular designs for embryonic pluripotency The transcriptional regulation of pluripotency From pluripotency to forebrain patterning: an in vitro journey astride embryonic stem cells Ventx factors function as Nanog-like guardians of developmental potential in Xenopus Human Cerberus prevents nodal-receptor binding, inhibits nodal signaling, and suppresses nodal-mediated phenotypes Chromatin structure of pluripotent stem cells and induced pluripotent stem cells.Molecular basis of embryonic stem cell self-renewal: from signaling pathways to pluripotency network TGF-β family signaling in stem cells Signaling through the TGF beta-activin receptors ALK4/5/7 regulates testis formation and male germ cell development Master transcription factors determine cell-type-specific responses to TGF-β signaling Differentiation of embryonic stem cells 1 (Dies1) is a component of bone morphogenetic protein 4 (BMP4) signaling pathway required for proper differentiation of mouse embryonic stem cells Dedifferentiation of foetal CNS stem cells to mesendoderm-like cells through an EMT process The PR/SET domain zinc finger protein Prdm4 regulates gene expression in embryonic stem cells but plays a nonessential role in the developing mouse embryo Overexpression of BCL2 enhances survival of human embryonic stem cells during stress and obviates the requirement for serum factors.Activin A Modulates CRIPTO-1/HNF4α+ Cells to Guide Cardiac Differentiation from Human Embryonic Stem Cells.MSX2 mediates entry of human pluripotent stem cells into mesendoderm by simultaneously suppressing SOX2 and activating NODAL signaling.A small-molecule inhibitor of tgf-Beta signaling replaces sox2 in reprogramming by inducing nanog.Cell fusion of bone marrow cells and somatic cell reprogramming by embryonic stem cells.Signaling Molecules Governing Pluripotency and Early Lineage Commitments in Human Pluripotent Stem Cells.Development of Scalable Culture Systems for Human Embryonic Stem Cells.NANOG reporter cell lines generated by gene targeting in human embryonic stem cells.Enhancement of human embryonic stem cell pluripotency through inhibition of the mitochondrial respiratory chain.Comparison of defined culture systems for feeder cell free propagation of human embryonic stem cells.The many faces of Pluripotency: in vitro adaptations of a continuum of in vivo states.NANOG Plays a Hierarchical Role in the Transcription Network Regulating the Pluripotency and Plasticity of Adipose Tissue-Derived Stem Cells.miR-373 is regulated by TGFβ signaling and promotes mesendoderm differentiation in human Embryonic Stem Cells.Role of Cripto-1 in stem cell maintenance and malignant progression.Stable methylation at promoters distinguishes epiblast stem cells from embryonic stem cells and the in vivo epiblasts.Emerging roles of microRNAs in the control of embryonic stem cells and the generation of induced pluripotent stem cells.The developmental dismantling of pluripotency is reversed by ectopic Oct4 expression.Activin A maintains pluripotency markers and proliferative potential of human induced pluripotent stem cells

P2860

Q24305109-0D559046-73D9-4862-96D6-1E56290739F9 Q24320356-C47D1811-02E3-4702-AEC5-F5BE9FEB7647 Q24337560-FC3A0430-4E24-4958-B47A-C469BE2588DA Q24644638-B34F8035-31E7-4FB0-AA75-99447E57A43C Q26751606-C4020020-E2DD-49F0-97DA-82C5E8346335 Q26766266-5ADDB33B-1447-4BEC-94EC-C53749055DC9 Q26769981-41A5F983-9954-4777-915F-A441592CBB1E Q26771912-9202D691-1AAA-4876-A406-279DEFC61A3B Q26777882-BA59FA96-F9D6-4128-84A7-F2D2AA9D756C Q26860750-1A937BC2-A0FB-40FA-861D-B15D2FAEB821 Q26866571-1CBD1481-70E5-4D79-A89D-ADEBB8677AA9 Q27030826-6D065EB7-1E23-481E-A2AB-ED76D534C91B Q27303118-19A4E763-66DB-4DEB-8667-C1E41AC8B71B Q27320887-1FC7E6C6-8C1B-495C-82A5-04FC893FCA8C Q27691396-8089D456-B87A-4A86-B06E-6DCAD305B6F1 Q28084007-6D397E7A-3C05-403E-99FC-647458BDC390 Q28274611-F87F59B3-A9BC-4C35-93CD-F2E384E3F16D Q28585371-7C419FE0-E4D6-4934-9864-B27CAA4958AD Q28586183-A544FD2B-9A5E-42A9-859C-F449C593874C Q28591978-2BFEE358-1570-455B-A512-23567E9AF9A8 Q28732522-B843941A-56B3-4DF5-B84D-D6EEF9B0BFC3 Q28854377-61A4EC1C-221E-43AA-AA03-6EF4919D0BCF Q30498247-5EB0AD56-8751-419E-BB90-6D9437C6DFCB Q30835763-11C1FF19-A93F-49C6-B9EE-4A9DA764DEE9 Q33361639-17999B2B-8E5A-442D-9E53-D75E0D692ACB Q33509682-E90DD4C7-3B91-49E3-99B7-51DD4A339B12 Q33613197-697D42E7-4CA6-4574-91AB-B61675022A4E Q33625794-18A9C486-F3DE-40F1-8A8C-E135B5CCAF59 Q33649690-358DF6DD-1981-4445-B7C3-B643354397CB Q33686972-CFC1B852-BC82-4643-A007-AA0258A54875 Q33723005-488690A6-67E7-4D8D-9A5A-58FC5923AEA0 Q33794176-F8A41380-77EA-49C6-8250-B6E4103AD289 Q33796203-C09C3B3D-EA7D-4981-8FF9-7796541A6C68 Q33838332-3D578423-19CA-4741-89E9-F3D4D8D0E7EE Q33844889-8EACF18C-5192-4985-92AF-FAC969482815 Q34033323-4A591F29-7D9A-41FF-8108-941A3FB75653 Q34081966-122AE5CD-7575-4AE2-BB4C-ECC62761200C Q34109542-F2768E2B-E783-462E-A184-EE796893CD8C Q34279160-90689244-F0D9-4F14-ABC4-6C8EDDE7B3EB Q34414522-5A48959F-DD8F-4A8E-9511-3766F0F9184F

P2860

Activin/Nodal signalling maintains pluripotency by controlling Nanog expression.

http://www.wikidata.org/entity/Q43121593

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh-hant

name

Activin/Nodal signalling maintains pluripotency by controlling Nanog expression.

@en

Activin/Nodal signalling maintains pluripotency by controlling Nanog expression.

@nl

type

label

Activin/Nodal signalling maintains pluripotency by controlling Nanog expression.

@en

Activin/Nodal signalling maintains pluripotency by controlling Nanog expression.

@nl

prefLabel

Activin/Nodal signalling maintains pluripotency by controlling Nanog expression.

@en

Activin/Nodal signalling maintains pluripotency by controlling Nanog expression.

@nl

P1433

Q43121593-A06BF31F-3A02-4140-88D0-605E584AA696

P1476

Q43121593-C65D0549-AAAC-4FD7-A341-BF86DD7F8AA2

P2093

Q43121593-0D033E1C-D191-4461-8800-C5162DCB683E

Q43121593-16755DFD-7B61-4734-98FC-2C6B43238205

Q43121593-2F3E35B3-5401-4C05-B782-5DD8A9DEE4A4

Q43121593-4382D3C4-B145-4B3D-95CC-7D6876DDE783

Q43121593-6A06BEDD-C8EF-4A44-8E13-E417F97E5A75

Q43121593-73333EDB-E7E0-4E14-9DCB-ED921CDFF698

Q43121593-B470F37A-8B19-4114-989E-FAFAE7F63BB5

Q43121593-B9B9FC97-21A1-41DB-B240-5536AAB57962

Q43121593-FC7529F1-32D6-4BBC-A933-3C8DFC721192

P2860

Q43121593-0084A71F-9821-48A3-903B-9C1145AAE23F

Q43121593-0508AD19-1B5A-4251-9F52-980A5F5A6744

Q43121593-15434301-C535-45C5-8040-E790A77DC7B2

Q43121593-1BA2D173-B257-43EA-997C-E1AE0D9EC201

Q43121593-1C8D483D-5089-4D6C-BDBC-E0E0202A3E76

Q43121593-22A67845-9CDB-4751-ACD5-0F58C2A779A6

Q43121593-290FD845-26CF-4409-A8BC-F99BDF3E1C08

Q43121593-2D83C9AD-D876-47EA-AC1D-56A4DFA414AA

Q43121593-3C8C2F5B-A916-4169-B2CC-5885302CE25C

Q43121593-3F52BD66-A034-4E11-BA36-CE1AC8E18D30

P304

Q43121593-388AD9CC-B470-47FF-B227-AD8B052B5483

P31

Q43121593-8EAD93DD-B5A5-4B5A-BCE5-975C7A18AB54

P356

Q43121593-CFF71245-07AE-4756-841C-8BACA5DBC4AC

P407

Q43121593-36B25454-D0B7-48BF-A959-1CA7581F2E54

P433

Q43121593-F2D353BF-359C-41C9-97FB-1617A647CDAE

P478

Q43121593-F7405CD7-73AB-4DFB-9B5C-18BFB4E43E44

P50

Q43121593-21FA65E3-6A28-495F-BF4D-DB9A29F1876E

Q43121593-55B173D8-13D8-4CC4-8B15-483497A559F8

Q43121593-CE72EF85-ECCE-4685-ADD9-46D7D1358EAA

P577

Q43121593-A4C849A4-62D7-4DC6-8650-16EB94C765BF

P698

Q43121593-9EB1EEFB-AE92-4153-9A78-405BDD630025

P932

Q43121593-B8F45450-F2C5-40DE-9241-7563FE903BC2

P356

P1433

P1476

Activin/Nodal signalling maintains pluripotency by controlling Nanog expression

@en

P2093

Amelie Martinez

http://www.w3.org/2001/XMLSchema#string

Candy H-H Cho

http://www.w3.org/2001/XMLSchema#string

Gabrielle Brons

http://www.w3.org/2001/XMLSchema#string

Lucy E Smithers

http://www.w3.org/2001/XMLSchema#string

Matthew W B Trotter

http://www.w3.org/2001/XMLSchema#string

Roger A Pedersen

http://www.w3.org/2001/XMLSchema#string

Sasha Mendjan

http://www.w3.org/2001/XMLSchema#string

Stephanie Brown

http://www.w3.org/2001/XMLSchema#string

Zhenzhi Chng

http://www.w3.org/2001/XMLSchema#string

P2860

Transforming growth factor beta -inducible independent binding of SMAD to the Smad7 promoter

Overexpression of NANOG in human ES cells enables feeder-free growth while inducing primitive ectoderm features

Core transcriptional regulatory circuitry in human embryonic stem cells

Identification, cloning and expression analysis of the pluripotency promoting Nanog genes in mouse and human

Induced pluripotent stem cell lines derived from human somatic cells

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells

Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells

Downregulation of NANOG induces differentiation of human embryonic stem cells to extraembryonic lineages

Combinatorial activities of Smad2 and Smad3 regulate mesoderm formation and patterning in the mouse embryo

P304

1339-1349

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1242/DEV.033951

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

136

http://www.w3.org/2001/XMLSchema#string

P50

Adrian Kee Keong Teo

Peter J Rugg-Gunn

Ludovic Vallier

P577

2009-03-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19279133

http://www.w3.org/2001/XMLSchema#string

P932

2687465

http://www.w3.org/2001/XMLSchema#string